Indexed in Journament

JAMA neurology

ISSN 2168-6157· EN

Login or register to claim ownership or editorship of this journal.
6
Articles Indexed

About This Journal

Short Name JAMA Neurol
Abbreviated Name jama neurol
ISSN 2168-6157

Indexings

ncbi ulakbim sci

Tools & Certificate of Indexing

Publications Per Year

Articles (6)

2019
Survival and Prognostic Factors in C9orf72 Repeat Expansion Carriers: A Systematic Review and Meta-analysis.
396 views DOI Abstract
2019
Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies.
353 views DOI Abstract
2019
Association Between Low-Dose Rivaroxaban With or Without Aspirin and Ischemic Stroke Subtypes: A Secondary Analysis of the COMPASS Trial.
314 views DOI Abstract
2019
Association of Intracranial Atherosclerotic Disease With Brain β-Amyloid Deposition: Secondary Analysis of the ARIC Study.
296 views DOI Abstract
2021
Burden of Neurological Disorders Across the US From 1990-2017: A Global Burden of Disease Study
Vol. 78 , No. 2 , pp. 165-176
209 views Abstract
2024
Parental History of Memory Impairment and β-Amyloid in Cognitively Unimpaired Older Adults.
Vol. 81 , No. 8 , pp. 798-804
70 views DOI Abstract
2024
Parental History of Memory Impairment and β-Amyloid in Cognitively Unimpaired Older Adults.
Vol. 81 , No. 8 , pp. 798-804
70 views DOI Abstract
2021
Burden of Neurological Disorders Across the US From 1990-2017: A Global Burden of Disease Study
Vol. 78 , No. 2 , pp. 165-176
209 views Abstract
2019
Survival and Prognostic Factors in C9orf72 Repeat Expansion Carriers: A Systematic Review and Meta-analysis.
396 views DOI Abstract
2019
Association of Intracranial Atherosclerotic Disease With Brain β-Amyloid Deposition: Secondary Analysis of the ARIC Study.
296 views DOI Abstract
2019
Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies.
353 views DOI Abstract
2019
Association Between Low-Dose Rivaroxaban With or Without Aspirin and Ischemic Stroke Subtypes: A Secondary Analysis of the COMPASS Trial.
314 views DOI Abstract
0
Overall
Not Rated
0
0
0
0
0
0
0
0
0
0
0